ASX:PYCBiotechs
Will PYC Therapeutics’ New CFO Shift Its Capital-Market Ambitions Up a Gear (ASX:PYC)?
PYC Therapeutics Limited recently appointed Mr. Thomas Ulmer as Chief Financial Officer, adding more than 20 years of international biotechnology, pharmaceutical and healthcare leadership to its executive team.
Ulmer’s prior experience guiding Immatics N.V. through its NASDAQ listing gives PYC access to finance leadership familiar with cross-border capital markets and public-company standards.
We’ll now examine how Ulmer’s international capital markets background, including NASDAQ listing...

